Our team selected a , the industry standard for mAbs due to its ability to perform human-like glycosylation—a critical factor for drug efficacy.
Starts with choosing a host cell (often CHO cells ) and optimizing the genetic expression of the antibody. A Mab A Case Study In Bioprocess Development
Low pH hold (pH 3.6 for 60 minutes) was used. But with A Mab’s sensitivity, they optimized to pH 3.7 for exactly 30 minutes – no longer, no shorter. Validation showed >4 log reduction of model virus (xMuLV). Our team selected a , the industry standard
The study follows a structured sequence typical of biopharmaceutical development: Our team selected a
The process begins by establishing the "end goal" before any manufacturing starts. International Society for Pharmaceutical Engineering (ISPE) Target Product Profile (TPP):